American International Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
RCMNY
MCMC
AIM
NAMA
American International Group's ADPT Position: Q2 2024 in Review
American International Group sold out of Adaptive Biotechnologies (ADPT) in Q2 2024, closing a stake of 55,983 shares — an estimated $180K sold.
American International Group first reported a position in ADPT in Q3 2019 and held it in 19 quarters. The position peaked at $475K in Q1 2023. 176 funds tracked by Wall St. Rank hold ADPT as of Q2 2024.
- American International Group reported no remaining Adaptive Biotechnologies position as of Q2 2024 after selling out during the quarter.
- American International Group sold 55,983 Adaptive Biotechnologies shares in Q2 2024, an estimated $180K.
- American International Group first reported a position in Adaptive Biotechnologies in Q3 2019 and held it in 19 quarters.
- American International Group's Adaptive Biotechnologies position peaked at $475K in Q1 2023.
- 176 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.